$14.85
+0.32 (+2.20%)
SGRY News2 articles
JNJ Stock Rises on China Approval and Digital Surgery Deal
Johnson & Johnson shares gained 1.13% Friday to $234.34, climbing 3.4% for the week, buoyed by a Chinese approval of its drug nipocalimab and a new digital surgery partnership in Abu Dhabi.
OpenEvidence Partners with SSO, Pushes AI Deeper into Cancer Surgery
OpenEvidence partners with the Society of Surgical Oncology to integrate clinical content into its AI platform and launch a $100,000 grant for surgeon-led research.